Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Melanoma × Cytarabine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 321 Leukemia 148 Precursor Cell Lymphoblastic Leukemia-Lymphoma 142 Lymphoma 98 Myelodysplastic Syndromes 65 Lymphoma, Non-Hodgkin 58 Lymphoma, Mantle-Cell 52 Burkitt Lymphoma 52 Lymphoma, Large B-Cell, Diffuse 50 Recurrence 48 Congenital Abnormalities 40 Leukemia, Monocytic, Acute 37 Leukemia, Myelomonocytic, Acute 32 Leukemia, Erythroblastic, Acute 32 Hodgkin Disease 32 Lymphoma, Follicular 31 Leukemia, Megakaryoblastic, Acute 30 Leukemia, Myelomonocytic, Chronic 25 Lymphoma, Large-Cell, Immunoblastic 24 Leukemia, Lymphocytic, Chronic, B-Cell 24 Leukemia, Biphenotypic, Acute 24 Blast Crisis 23 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 18 Myeloproliferative Disorders 17 Anemia, Refractory, with Excess of Blasts 17 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 16 Lymphoma, B-Cell, Marginal Zone 16 Neoplasm, Residual 13 Leukemia, Myeloid, Chronic-Phase 13 Leukemia, Myeloid, Accelerated Phase 13

Interventions

Nivolumab 130 Ipilimumab 122 pembrolizumab 110 Cyclophosphamide 72 Interleukin-2 60 aldesleukin 57 Temozolomide 40 Radiosurgery 36 trametinib 34 Vemurafenib 34 Biopsy 32 fludarabine 31 Blood Specimen Collection 31 dabrafenib 30 Radiotherapy 30 fludarabine phosphate 27 sargramostim 26 Bevacizumab 25 Introns 21 Magnetic Resonance Spectroscopy 20 Dacarbazine 20 encorafenib 17 cobimetinib 17 binimetinib 17 Specimen Handling 17 Granulocyte-Macrophage Colony-Stimulating Factor 17 Paclitaxel 16 Cisplatin 16 incomplete Freund's adjuvant 14 montanide ISA 51 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00779714 2008-10-24

ChemoSensMM

University of Wuerzburg

Phase 3 Unknown

Melanoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡